Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

References

• LaursenTMMunk-OlsenTVestergaardMLife expectancy and cardiovascular mortality in persons with schizophreniaCurr Opin Psychiatry201225838822249081
   PubMed Web of Science ®Google Scholar
• SrihariVHPhutaneVHOzkanBCardiovascular mortality in schizophrenia: defining a critical period for preventionSchizophr Res2013146646823422728
   PubMed Web of Science ®Google Scholar
• SuttajitSPilakantaSPrevalence of metabolic syndrome and its association with depression in patients with schizophreniaNeuropsychiatr Dis Treat2013994194623882141
   PubMed Web of Science ®Google Scholar
• VancampfortDProbstMScheeweTRelationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophreniaPsychiatry Res2013207253223051886
   PubMed Web of Science ®Google Scholar
• De HertMDetrauxJvan WinkelRYuWCorrellCUMetabolic and cardiovascular adverse effects associated with antipsychotic drugsNat Rev Endocrinol2012811412622009159
   PubMed Web of Science ®Google Scholar
• de AraujoANde SenaEPde OliveiraIRJuruenaMFAntipsychotic agents: efficacy and safety in schizophreniaDrug Healthc Patient Saf2012417318023236256
   PubMedGoogle Scholar
• BodenREdmanGReutforsJOstensonCGOsbyUA comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practiceNeuropsychiatr Dis Treat2013937137723682213
   PubMed Web of Science ®Google Scholar
• NewcomerJWMetabolic considerations in the use of antipsychotic medications: a review of recent evidenceJ Clin Psychiatry200768Suppl 1S20S27
   PubMed Web of Science ®Google Scholar
• SchorrSGSlooffCJBruggemanRTaxisKThe incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one yearJ Psychiatr Res2009431106111119398113
   PubMed Web of Science ®Google Scholar
• De HertMvan WinkelRVan EyckDPrevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studyClin Pract Epidemiol Ment Health200621416803620
   PubMedGoogle Scholar
• RyanMCCollinsPThakoreJHImpaired fasting glucose tolerance in first-episode, drug-naive patients with schizophreniaAm J Psychiatry200316028428912562574
   PubMed Web of Science ®Google Scholar
• SpelmanLMWalshPISharifNCollinsPThakoreJHImpaired glucose tolerance in first-episode drug-naive patients with schizophreniaDiabet Med20072448148517381506
   PubMed Web of Science ®Google Scholar
• VermaSKSubramaniamMLiewAPoonLYMetabolic risk factors in drug-naive patients with first-episode psychosisJ Clin Psychiatry200970997100019497246
   PubMed Web of Science ®Google Scholar
• LettTAWallaceTJChowdhuryNITiwariAKKennedyJLMullerDJPharmacogenetics of antipsychotic-induced weight gain: review and clinical implicationsMol Psychiatry20121724226621894153
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection ETreatment of High Blood Cholesterol in A. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA20012852486249711368702
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIDanielsSRDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation20051122735275216157765
   PubMed Web of Science ®Google Scholar
• LearSATomaMBirminghamCLFrohlichJJModification of the relationship between simple anthropometric indices and risk factors by ethnic backgroundMetabolism2003521295130114564681
   PubMed Web of Science ®Google Scholar
• TanCEMaSWaiDChewSKTaiESCan we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?Diabetes Care2004271182118615111542
   PubMed Web of Science ®Google Scholar
• RuskovskaTBernlohrDAOxidative stress and protein carbonylation in adipose tissue – implications for insulin resistance and diabetes mellitusJ Proteomics4112013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Codoner-FranchPValls-BellesVArilla-CodonerAAlonso-IglesiasEOxidant mechanisms in childhood obesity: the link between inflammation and oxidative stressTransl Res201115836938422061044
   PubMed Web of Science ®Google Scholar
• MonteroDWaltherGPerez-MartinARocheEVinetAEndothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle interventionObes Rev20121344145522133012
   PubMed Web of Science ®Google Scholar
• BarterPHDL-C: role as a risk modifierAtheroscler Suppl20111226727022152280
   PubMed Web of Science ®Google Scholar
• KontushAChapmanMJFunctionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosisPharmacol Rev20065834237416968945
   PubMed Web of Science ®Google Scholar
• GinsbergGSmolenskiSHattisDGuytonKZJohnsDOSonawaneBGenetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activityJ Toxicol Environ Health B Crit Rev20091238943920183528
   PubMed Web of Science ®Google Scholar
• HayesJDFlanaganJUJowseyIRGlutathione transferasesAnnu Rev Pharmacol Toxicol200545518815822171
   PubMed Web of Science ®Google Scholar
• JiJDLeeWJAssociation between the polymorphisms of glutathione S-transferase genes and rheumatoid arthritis: a meta-analysisGene201352115515923537991
   PubMed Web of Science ®Google Scholar
• HoriMOnikiKUedaKCombined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in JapanesePharmacogenomics200781307131417979505
   PubMed Web of Science ®Google Scholar
• KarizSNikolajevic StarcevicJPetrovicDAssociation of manganese superoxide dismutase and glutathione S-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitusDiabetes Res Clin Pract20129814415022858312
   PubMed Web of Science ®Google Scholar
• Santl LetonjaMLetonjaMIkolajevic-StarcevicJNPetrovicDAssociation of manganese superoxide dismutase and glutathione S-transferases genotypes with carotid atherosclerosis in patients with diabetes mellitus type 2Int Angiol201231334122330623
   PubMed Web of Science ®Google Scholar
• OnikiKHoriMSaruwatariJInteractive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver diseaseToxicol Lett201322014314923643483
   PubMed Web of Science ®Google Scholar
• FukaiTUshio-FukaiMSuperoxide dismutases: role in redox signaling, vascular function, and diseasesAntioxid Redox Signal2011151583160621473702
   PubMed Web of Science ®Google Scholar
• SuttonAImbertAIgoudjilAThe manganese superoxide dismutase Ala 16 Val dimorphism modulates both mitochondrial import and mRNA stabilityPharmacogenet Genomics20051531131915864132
   PubMed Web of Science ®Google Scholar
• TianCFangSDuXJiaCAssociation of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysisDiabetologia20115480381121181397
   PubMed Web of Science ®Google Scholar
• BitanihirweBKWooTUOxidative stress in schizophrenia: an integrated approachNeurosci Biobehav Rev20113587889320974172
   PubMed Web of Science ®Google Scholar
• WuJQKostenTRZhangXYFree radicals, antioxidant defense systems, and schizophreniaProg Neuropsychopharmacol Biol Psychiatry20134620020623470289
   PubMed Web of Science ®Google Scholar
• ZhangXYYaoJKOxidative stress and therapeutic implications in psychiatric disordersProg Neuropsychopharmacol Biol Psychiatry20134619719923523744
   PubMed Web of Science ®Google Scholar
• ParkYMLeeHJKangSGChoiJEChoJHKimLLack of association between glutathione S-transferase-M1, -T1, and -P1 polymorphisms and olanzapine-induced weight gain in Korean schizophrenic patientsPsychiatry Investig20107147152
   Web of Science ®Google Scholar
• SugawaraNYasui-FurukoriNSatoYPrevalence of metabolic syndrome among patients with schizophrenia in JapanSchizophr Res201012324425020850274
   PubMed Web of Science ®Google Scholar
• WatanabeITomitaAShimizuMA study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitusClin Pharmacol Ther20037343545512732844
   PubMed Web of Science ®Google Scholar
• NisaHKonoSYinGCigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer StudyBMC Cancer20101027420534171
   PubMed Web of Science ®Google Scholar
• TeranishiMUchidaYNishioNPolymorphisms in genes involved in oxidative stress response in patients with sudden sensorineural hearing loss and Meniere’s disease in a Japanese populationDNA Cell Biol2012311555156222877234
   PubMed Web of Science ®Google Scholar
• MacielSSPereira AdaCSilvaGJRodriguesMVMillJGKriegerJEAssociation between glutathione S-transferase polymorphisms and triglycerides and HDL-cholesterolAtherosclerosis200920620420819419718
   PubMed Web of Science ®Google Scholar
• Di PietroGMagnoLARios-SantosFGlutathione S-transferases: an overview in cancer researchExpert Opin Drug Metab Toxicol2010615317020078251
   PubMed Web of Science ®Google Scholar
• ZhangJLiuHYanHHuangGWangBNull genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a metaanalysisGene201351840541123296061
   PubMed Web of Science ®Google Scholar
• KroppSKernVLangeKOxidative stress during treatment with first- and second-generation antipsychoticsJ Neuropsychiatry Clin Neurosci20051722723115939978
   PubMed Web of Science ®Google Scholar
• PillaiAParikhVTerryAVJrMahadikSPLong-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brainJ Psychiatr Res20074137238616564057
   PubMed Web of Science ®Google Scholar